Metastatic hidradenocarcinoma: efficacy of capecitabine.
Jouary
Thomas
T
Kaiafa
Anastasia
A
Lipinski
Philippe
P
Vergier
Béatrice
B
Lepreux
Sébastien
S
Delaunay
Michèle
M
Taïeb
Alain
A
D006607:Adenoma, Sweat Gland / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001365:Axilla; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D004550:Elbow; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013544:Sweat Gland Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil